ELITE PHARMACEUTICALS INC /NV/ Earnings Per Share Diluted

Quick Answer

ELITE PHARMACEUTICALS INC /NV/ reported Earnings Per Share Diluted of $0.00 per share for the year ending 2025.

  • ELITE PHARMACEUTICALS INC /NV/ showed a decrease of -100.0% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from ELITE PHARMACEUTICALS INC /NV/'s annual report (Form 10-K), filed with the SEC on June 30, 2025.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2012 to 2025), ELITE PHARMACEUTICALS INC /NV/'s Earnings Per Share Diluted has grown by 100.0%.
  • Historical annual values: Fiscal year 2025: $0.00 per share | Fiscal year 2024: $0.02 per share | Fiscal year 2023: $0.00 per share | Fiscal year 2022: $0.01 per share | Fiscal year 2021: $0.00 per share | Fiscal year 2020: $0.00 per share | Fiscal year 2019: $0.01 (loss) per share | Fiscal year 2018: $0.01 (loss) per share | Fiscal year 2017: $0.01 (loss) per share | Fiscal year 2016: $0.01 (loss) per share | Fiscal year 2015: $0.02 (loss) per share | Fiscal year 2014: $0.21 (loss) per share | Fiscal year 2013: $0.00 per share | Fiscal year 2012: $0.06 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: